Kenneth C. Frazier is chairman of the board and chief executive officer of Merck & Co., Inc.

Previously, Ken served as president of Merck with responsibility for the company’s three major divisions: Global Human Health, Merck’s sales and marketing division for pharmaceutical and vaccine products; Merck Manufacturing Division; and Merck Research Laboratories. Ken has held a broad range of senior management positions since joining Merck in 1992 as vice president, general counsel and secretary of the Astra Merck Group.

Prior to joining Merck, Ken was a partner with the Philadelphia law firm of Drinker Biddle & Reath. Ken sits on the boards of PhRMA, Weill Cornell Medicine, Exxon Mobil Corporation and Cornerstone Christian Academy in Philadelphia, PA. He also is a member of the American Academy of Arts and Sciences, the President’s Export Council, The Business Council, the Council of the American Law Institute and the American Bar Association. Ken received his bachelor’s degree from The Pennsylvania State University and holds a J.D. from Harvard Law School.